Treace Medical Concepts (TMCI) Competitors

Treace Medical Concepts (NASDAQ:TMCI) and LeMaitre Vascular (NASDAQ:LMAT) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, media sentiment, risk, community ranking, profitability, institutional ownership, analyst recommendations, earnings and valuation.

Is TMCI or LMAT more profitable?

LeMaitre Vascular has a net margin of 19.40% compared to Treace Medical Concepts' net margin of -30.33%. LeMaitre Vascular's return on equity of 13.15% beat Treace Medical Concepts' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Treace Medical Concepts	-30.33%	-51.12%	-26.36%
LeMaitre Vascular	19.40%	13.15%	11.47%

Which has higher earnings and valuation, TMCI or LMAT?

LeMaitre Vascular has higher revenue and earnings than Treace Medical Concepts. Treace Medical Concepts is trading at a lower price-to-earnings ratio than LeMaitre Vascular, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Treace Medical Concepts	$209.36M	2.60	-$49.53M	-$0.90	-9.66
LeMaitre Vascular	$219.86M	8.83	$30.10M	$1.94	44.37

Does the MarketBeat Community prefer TMCI or LMAT?

LeMaitre Vascular received 489 more outperform votes than Treace Medical Concepts when rated by MarketBeat users. Likewise, 70.45% of users gave LeMaitre Vascular an outperform vote while only 45.61% of users gave Treace Medical Concepts an outperform vote.

Company	Underperform	Outperform
Treace Medical Concepts	Outperform Votes 26 45.61%	Underperform Votes 31 54.39%
LeMaitre Vascular	Outperform Votes 515 70.45%	Underperform Votes 216 29.55%

Which has more volatility & risk, TMCI or LMAT?

Treace Medical Concepts has a beta of 0.77, indicating that its stock price is 23% less volatile than the S&P 500. Comparatively, LeMaitre Vascular has a beta of 0.89, indicating that its stock price is 11% less volatile than the S&P 500.

Does the media prefer TMCI or LMAT?

In the previous week, Treace Medical Concepts had 2 more articles in the media than LeMaitre Vascular. MarketBeat recorded 8 mentions for Treace Medical Concepts and 6 mentions for LeMaitre Vascular. LeMaitre Vascular's average media sentiment score of 1.43 beat Treace Medical Concepts' score of 0.73 indicating that LeMaitre Vascular is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Treace Medical Concepts	5 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
LeMaitre Vascular	5 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Do institutionals & insiders have more ownership in TMCI or LMAT?

84.1% of Treace Medical Concepts shares are held by institutional investors. Comparatively, 84.6% of LeMaitre Vascular shares are held by institutional investors. 24.4% of Treace Medical Concepts shares are held by company insiders. Comparatively, 10.8% of LeMaitre Vascular shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Do analysts rate TMCI or LMAT?

Treace Medical Concepts presently has a consensus target price of $10.14, indicating a potential upside of 16.72%. LeMaitre Vascular has a consensus target price of $95.25, indicating a potential upside of 10.67%. Given Treace Medical Concepts' higher possible upside, research analysts plainly believe Treace Medical Concepts is more favorable than LeMaitre Vascular.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Treace Medical Concepts	0 Sell rating(s)	5 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.29
LeMaitre Vascular	0 Sell rating(s)	4 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.67

Summary

LeMaitre Vascular beats Treace Medical Concepts on 16 of the 19 factors compared between the two stocks.